Format

Send to

Choose Destination
Ann Oncol. 2014 Sep;25(9):1863-5. doi: 10.1093/annonc/mdu245. Epub 2014 Jul 10.

Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014).

Author information

1
Department of Radiation Oncology, Catholic University of the Sacred Heart, Rome, Italy European SocieTy for Radiotherapy and Oncology (ESTRO), Brussels, Belgium.
2
Department of Urology, Skåne University Hospital, Malmö, Sweden European Association of Urology (EAU), Arnhem, The Netherlands.
3
School of Health Sciences, University of Melbourne, Melbourne, Australia Union for International Cancer Control (UICC), Geneva, Switzerland.
4
Department of Pharmacy, Henri Mondor University Hospitals, Créteil, France European Society of Oncology Pharmacy (ESOP), Luxembourg, Luxembourg.
5
Department of Surgery, University of Liverpool, St Helens Teaching Hospital, St Helens, UK European Society of Surgical Oncology (ESSO), Brussels, Belgium.
6
University of Strathclyde Institute of Global Public Health at iPRI, International Prevention Research Institute, Lyon, France Euroskin, Hamburg, Germany.
7
Department of Radiological Sciences, Catholic University of the Sacred Heart, Rome, Italy European Society of Radiology (ESR), Vienna, Austria.
8
Department of Thoracic Surgery, St James's University Hospital, Leeds, UK European Society of Thoracic Surgeons (ESTS), Exeter, UK.
9
Division of Psychosocial Oncology, Department of Oncology, University of Calgary, Calgary, Canada International Psycho-Oncology Society (IPOS), Charlottesville, USA.
10
Department of Nuclear Medicine, Istituto Clinico Humanitas, Milan, Italy European Association of Nuclear Medicine (EANM), Vienna, Austria.
11
European Cancer Patient Coalition (ECPC), Brussels, Belgium.
12
Department of Oncology, Odense University Hospital, Odense, Denmark European Union of Medical Specialists (UEMS), UEMS Section of Radiation Oncology and Radiotherapy, Brussels, Belgium.
13
Division of Imaging Sciences and Biomedical Engineering, St Thomas' Hospital, London, UK European Society of Oncologic Imaging (ESOI), Vienna, Austria.
14
Union for International Cancer Control (UICC), Geneva, Switzerland University of Toronto, Princess Margaret Cancer Centre, Toronto, Canada.
15
Institute of Clinical Psychiatry, Department of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy IPOS Federation of Psycho-Oncology Societies, Charlottesville, USA.
16
Association of European Cancer Leagues (ECL), Brussels, Belgium.
17
Department of Radiation Therapy, University of Leipzig, Leipzig, Germany Paediatric Radiation Oncology Society (PROS), Lyon, France.
18
Union for International Cancer Control (UICC), Geneva, Switzerland Department of Pediatric Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
19
Myeloma Patients Europe, Brussels, Belgium.
20
European Society of Surgical Oncology (ESSO), Brussels, Belgium Department of Surgery, University of Liverpool, Aintree University Hospital, Liverpool, UK.
21
Cancer Center, Helsinki University Central Hospital, Helsinki, Finland European Association for Palliative Care (EAPC), Milan, Italy.
22
Department Neuro-Oncology, University, Turin, Italy European Association of Neuro-Oncology (EANO), Brussels, Belgium.
23
Department of Medical Physics, Niguarda Ca' Granda Hospital, Milan, Italy European Federation of Organizations for Medical Physics (EFOMP), York , UK.
24
Executive Board Member Netherlands Cancer Institute, Amsterdam, The Netherlands Organization of European Cancer Institutes (OECI), Brussels, Belgium.
25
European Association of Nuclear Medicine (EANM), Vienna, Austria Department of Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.
26
National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ) Heidelberg, Germany European Association for Cancer Research (EACR), Nottingham, UK.
27
European SocieTy for Radiotherapy and Oncology (ESTRO), Brussels, Belgium Department of Radiation Oncology, Dr B. Verbeeten Institute, Tilburg, The Netherlands poortmans.ph@bvi.nl.
PMID:
25015332
DOI:
10.1093/annonc/mdu245
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center